During the past decade, Ospedali Riuniti di Ancona conducted 168 clinical trials. In the 10-year time frame, 168 clinical trials started and 57 clinical trials were completed, i.e. on average, 33.9% percent of trials that started reached the finish line to date. In the past 5 years, 75 clinical trials started and 46 clinical trials were completed. i.e. 61.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedali Riuniti di Ancona" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 27 trials, followed by "Università Politecnica delle Marche" with 14 trials sponsored, "Hoffmann-La Roche" with 13 trials sponsored, "Celgene" with 12 trials sponsored and "Fondazione Italiana Linfomi ONLUS" with 12 trials sponsored. Other sponsors include 174 different institutions and companies that sponsored additional 107 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedali Riuniti di Ancona" #1 collaborator was "AbbVie" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Azienda Ospedaliero, Universitaria Ospedali Riuniti" with 2 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 2 trials as a collaborator and "Catholic University of the Sacred Heart" with 2 trials as a collaborator. Other collaborators include 156 different institutions and companies that were collaborators in the rest 159 trials.

According to Clinical.Site data, the most researched conditions in "Ospedali Riuniti di Ancona" are "Multiple Myeloma" (19 trials), "Cystic Fibrosis" (8 trials), "Breast Cancer" (7 trials), "Chronic Myeloid Leukemia" (6 trials) and "Leukemia" (6 trials). Many other conditions were trialed in "Ospedali Riuniti di Ancona" in a lesser frequency.

Most popular intervention types in "Ospedali Riuniti di Ancona" are "Drug" (179 trials), "Other" (34 trials), "Device" (20 trials), "Procedure" (15 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Dexamethasone" (11 trials), "Lenalidomide" (8 trials), "Pomalidomide" (7 trials) and "IVA" (6 trials). Other intervention names were less common.

The vast majority of trials in "Ospedali Riuniti di Ancona" are 246 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedali Riuniti di Ancona". 1 are not yet recruiting, 47 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 129 completed trials in Ospedali Riuniti di Ancona, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedali Riuniti di Ancona, 9 "Phase 1" clinical trials were conducted, 66 "Phase 2" clinical trials and 96 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 22 trials that are defined as “Not Applicable".

Ospedali Riuniti di Ancona has several departments that took part in Clinical trials: "Ospedali Riuniti Di Ancona; Oncology" - 5 trials, "Clinica Oncologica-Ospedali Riuniti Ancona" - 3 trials, "AOU Ospedali Riuniti Umberto I-G.M. Lancisi-G. Salesi; SOD Clinica Neurologica-Am.Sclerosi Multipla" - 2 trials